Immunology and Microbiology
Measles
100%
Rubella
91%
Virus
56%
Measles Virus
52%
Swine Influenza Virus
47%
Virus Antibody
47%
Cladistics
45%
Influenza A Virus (H1N1)
45%
Virus Strain
43%
Hepatitis B Virus
36%
Immunoglobulin M
29%
Immunoglobulin G Antibody
23%
Neutralization
23%
Severe Acute Respiratory Syndrome Coronavirus 2
23%
Omicron Coronavirus Variant
23%
Hepatitis B Virus Genotype A
23%
Human Parvovirus B19
23%
Seroprevalence
23%
Prevalence
23%
Breakthrough Infection
23%
Immunoglobulin G
18%
Neutralizing Antibody
17%
Antibody Titer
15%
Spike
14%
Receptor Binding
11%
Seropositivity
11%
Viral Load
11%
Rubella Virus
10%
Hepatitis B
10%
Reverse Transcription Polymerase Chain Reaction
8%
Genetic Variability
7%
First Trimester Pregnancy
5%
Real Time Polymerase Chain Reaction
5%
High Risk Population
5%
ELISA
5%
Urban Population
5%
Immunoglobulin M Antibody
5%
Cross-Reactivity
5%
Aves
5%
Keyphrases
Subtype H1N1
28%
Vaccine Breakthrough
23%
SARS-CoV-2 Omicron
23%
Breakthrough Infection
23%
Swine
23%
Omicron BA.1
23%
Cross-neutralization
23%
B Cell Repertoire
23%
Heavy Chain
23%
Swine Influenza Virus
23%
HBV-related Hepatocellular Carcinoma
23%
Virus-neutralizing Antibody
23%
Measles Virus
23%
Failure to Vaccinate
23%
Western Europe
23%
Antibody Prevalence
23%
Molecular Characterization
23%
Central African Republic
23%
Influenza
20%
Virus
20%
Spike Protein
19%
Low Virulence
17%
AFP-L3
17%
Genotype
14%
Measles
14%
Oral Swab
12%
Unvaccinated
11%
Prevalence Study
9%
Africa
9%
Sequential Exposure
9%
Virus Pandemic
9%
Serological Response
9%
Moderate Disease
7%
Variants of Concern
7%
Israel
7%
Genotype 3
7%
H1N1 Virus
6%
Pandemic (H1N1) 2009 Virus
6%
Neutralizing Antibodies
6%
Viral Disease
5%
Main Reservoir
5%
Natural Reservoir
5%
Specimen Type
5%
LaSota
5%
Neighbouring Countries
5%
Fusion Protein Cleavage Site
5%
Continuous Surveillance
5%
Winter Sports Resorts
5%
Multiple Specimens
5%
Free-range
5%
Biochemistry, Genetics and Molecular Biology
Genotyping
81%
Measles Virus
50%
Cladistics
38%
Virus Strain
33%
Immunoglobulin M
33%
Human Parvovirus B19
23%
Transgenic Rat
23%
B-Cell Receptor
23%
Intravenous Immunoglobulin
23%
B Cell
23%
Heavy Chain
13%
Retrospective Study
9%